GO:0047787 Delta4-3-oxosteroid 5beta-reductase activity

Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787) is a molecular function that catalyzes the NADPH-dependent reduction of the double bond at the 4-position of 3-oxo-Delta(4)-steroids, yielding 5beta-reduced steroid metabolites. This reaction sits at a branch point in steroid metabolism: it converts hormonally active Delta(4)-3-ketosteroids into 5beta-reduced forms and also participates in the conversion of bile acid intermediates. The human enzyme efficiently catalyzes the reduction of progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone to 5beta-reduced metabolites, and can also act on aldosterone, corticosterone and cortisol, though to a lesser extent. In addition, the bile acid intermediates 7alpha,12alpha-dihydroxy-4-cholesten-3-one and 7alpha-hydroxy-4-cholesten-3-one can serve as substrates. For researchers, GO:0047787 is important because it defines a catalytic activity that connects steroid hormone inactivation with bile acid biosynthesis. Because the enzyme accepts both hormonal steroids and bile acid precursors, changes in its expression or activity can simultaneously affect endocrine signaling and bile acid pool composition. The activity is therefore a useful functional node for studies of hepatic steroid metabolism, cholestatic disease models, and endocrine disorders. Mechanistically, the reaction consumes NADPH and releases NADP+ and a proton, and the enzyme is described as acting on a broad set of 3-oxo-Delta(4)-steroid substrates. This broad substrate tolerance makes GO:0047787 a good target for functional genomics: CRISPR-based perturbation of the encoding gene can be used to test which substrates and downstream pathways depend on this activity in a given cell type.

In plain terms, GO:0047787 describes an enzyme activity that removes a double bond from the 4-position of a 3-oxo-steroid, using NADPH as the reducing cofactor and producing a 5beta-reduced steroid, NADP+ and a proton. The official reaction is: a 3-oxo-5beta-steroid + NADP+ = a 3-oxo-Delta(4)-steroid + H+ + NADPH. The human enzyme efficiently reduces progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone to 5beta-reduced metabolites, and can also act on aldosterone, corticosterone and cortisol to a lesser extent. Bile acid intermediates such as 7alpha,12alpha-dihydroxy-4-cholesten-3-one and 7alpha-hydroxy-4-cholesten-3-one can also act as substrates. Synonyms include 3-oxo-Delta(4)-steroid 5-beta-reductase activity, Delta4-3-ketosteroid 5beta-reductase activity, and steroid 5beta-reductase activity.

GO:0047787 is important because it defines a catalytic step that simultaneously influences steroid hormone metabolism and bile acid biosynthesis. The human enzyme efficiently reduces progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone to 5beta-reduced metabolites, and can also act on aldosterone, corticosterone and cortisol to a lesser extent. Because bile acid intermediates such as 7alpha,12alpha-dihydroxy-4-cholesten-3-one and 7alpha-hydroxy-4-cholesten-3-one are also substrates, the activity sits at the interface of endocrine and hepatic metabolic pathways. Its expression is subject to differential feedback regulation by bile acids, which makes it a dynamic node in sterol and bile acid homeostasis. For experimental biologists, this means that perturbing the activity can reveal how cells balance hormone inactivation against bile acid precursor conversion, and can help interpret phenotypes in cholestasis, steroidogenic disorders and metabolic disease models.

The following genes and proteins are directly or functionally associated with Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787) and its substrate and product pathways, based on the verified literature.

Expression of the Delta4-3-oxosteroid 5beta-reductase is subject to differential feedback regulation by bile acids. This feedback means that bile acid levels can modulate the abundance of the activity, providing a homeostatic mechanism that adjusts both steroid hormone reduction and bile acid precursor conversion. Because the enzyme accepts both hormonal steroids and bile acid intermediates as substrates, this regulation can coordinate endocrine and hepatic metabolic outputs. Researchers can test the feedback axis by manipulating bile acid levels and measuring enzyme expression and 5beta-reduced product formation.

Because the enzyme accepts bile acid intermediates such as 7alpha,12alpha-dihydroxy-4-cholesten-3-one and 7alpha-hydroxy-4-cholesten-3-one as substrates, changes in its activity can affect bile acid precursor conversion. Its expression is under differential feedback regulation by bile acids, so disease states with altered bile acid levels may perturb this feedback loop. Experimental models that manipulate bile acid load and measure 5beta-reduced products can help define how the activity contributes to cholestatic phenotypes.

The human enzyme efficiently reduces progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone to 5beta-reduced metabolites, and can also act on aldosterone, corticosterone and cortisol to a lesser extent. This places the activity in the clearance and inactivation routes of multiple steroid hormones. Altered activity could therefore change the balance of active versus 5beta-reduced steroids, which is relevant to endocrine and metabolic disease research.

The dual substrate range of the enzyme links steroid hormone metabolism with bile acid biosynthesis in the liver. In hepatic metabolic disease models, perturbation of the activity can be used to test whether steroid and bile acid phenotypes are causally connected. CRISPR-based knockout or overexpression of the encoding gene provides a direct way to probe these links.

Direct measurement of Delta4-3-oxosteroid 5beta-reductase activity uses the defined reaction: a 3-oxo-5beta-steroid + NADP+ = a 3-oxo-Delta(4)-steroid + H+ + NADPH. Assays can monitor NADPH consumption or product formation with substrates such as progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone. Bile acid intermediates 7alpha,12alpha-dihydroxy-4-cholesten-3-one and 7alpha-hydroxy-4-cholesten-3-one can also be used as substrates to test the bile acid branch.

Because expression of the enzyme is under differential feedback regulation by bile acids, quantitative expression analysis after bile acid manipulation is a key method. Comparing transcript and protein levels across bile acid conditions reveals the direction and magnitude of feedback. This approach can be combined with activity assays to link expression changes to catalytic output.

Metabolite profiling measures the 5beta-reduced products generated from hormonal and bile acid substrates. Profiling can distinguish efficient substrates such as progesterone, androstenedione, 17alpha-hydroxyprogesterone and testosterone from lesser substrates such as aldosterone, corticosterone and cortisol. It can also track conversion of bile acid intermediates, connecting the activity to bile acid pool composition.

CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of the activity in cells. Combining genetic perturbation with activity assays and metabolite profiling shows which substrates and pathways depend on the enzyme. Such experiments are especially useful in hepatic and steroidogenic cell models where both steroid and bile acid substrates are present.

Researchers studying Delta4-3-oxosteroid 5beta-reductase activity-related genes often need to determine whether a candidate gene is causally involved in steroid and bile acid metabolism, and CRISPR-based models provide a direct route to that causal test.

Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787) is a NADPH-dependent molecular function that reduces 3-oxo-Delta(4)-steroids to 5beta-reduced products and also accepts bile acid intermediates as substrates. Its broad substrate range and bile acid feedback regulation place it at the intersection of steroid hormone metabolism and bile acid biosynthesis. For researchers, CRISPR-based knockout, point-mutation, knock-in and overexpression models provide direct causal tests of how this activity shapes metabolic phenotypes.